Abuso de drogas y biomarcadores séricos nutricionales: Un estudio retrospectivo de cohorte by Silva Ochoa, Alfonso Daniel et al.
Rev Esp Nutr Hum Diet. 2021; 25(2).
doi: 10.14306/renhyd.25.2.1157 [ahead of print]
Freely available online - OPEN ACCESS
 
Revista Española de Nutrición Humana y Dietética
Spanish Journal of Human Nutrition and Dietetics 
RESEARCH – post-print version 
This is the accepted peer-reviewed version for publication. The article can receive style and
format modifications.
Drug abuse and serum nutritional biomarkers: A retrospective cohort study
Abuso de drogas y biomarcadores séricos nutricionales: Un estudio
retrospectivo de cohorte
Alfonso Daniel Silva Ochoaa, José Alejandro Valdevila Figueirab, Rocío Valdevila Santiestebanc,
Diego  Javier  Estrella  Almeidab,*,  Luz  Maria  Valencia  Erazoa,  Andrea  Katherine  Orellana
Manzanoa.
a Laboratorio para Investigaciones Biomédicas, Facultad de Ciencias de la Vida, Escuela Superior
Politécnica del Litoral, Guayaquil, Ecuador.
b Instituto de Neurociencias, Guayaquil, Ecuador.
c Universidad de Ciencias Médicas, Holguín, Cuba.
* djeadiego@hotmail.com
Received: 09/29/2020; accepted: 01/24/2021; Posted: 02/03/2021
CITA: Silva  Ochoa  AD,  Valdevila  Figueira  JA,  Valdevila  Santiesteban  R,  Estrella  Almeida  DJ,
Valencia  Erazo  LM,  Orellana  Manzano  AK.  Drug  abuse  and  serum  nutritional  biomarkers:  A
retrospective cohort study. Rev Esp Nutr Hum Diet. 2021; 25(2). doi: 10.14306/renhyd.25.2.1157
[ahead of print]
La Revista Española de Nutrición Humana y Dietética se esfuerza por mantener a un sistema de publicación continua, de 
modo que los artículos se publican antes de su formato final (antes de que el número al que pertenecen se haya cerrado 
y/o publicado). De este modo, intentamos poner los artículos a disposición de los lectores/usuarios lo antes posible.
The Spanish Journal of Human Nutrition and Dietetics strives to maintain a continuous publication system, so that the 
articles are published before its final format (before the number to which they belong is closed and/or published). In this 
way, we try to put the articles available to readers/users as soon as possible.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Rev Esp Nutr Hum Diet. 2021; 25(2). Freely available online - OPEN ACCESS
doi: 10.14306/renhyd.25.2.1157 [ahead of print]
ABSTRACT
Introduction: Drug abuse is a public health problem around the globe. Its implications in human
health are harmful,  compromising nutritional  status.  It  has been shown that  malnutrition is
moderately prevalent in drug addicts, and a nutritional prescription is significantly beneficial for
these  patients.  Available  literature  suggests  altered  blood  serum  biochemical  data  in  drug
addicts. Our study focused on blood serum nutritional biomarkers in drug addicts who did not
have a nutritional assessment or treatment. This study aimed to analyze nutritional blood serum
biomarkers in subjects diagnosed with drug addiction from January 2010 to June 2020.
Methods: The research was a retrospective cohort, analytical, observational, and was based on a
convenience sample. Data about  blood serum AST, ALT, fasting glucose, urea, creatinine, total
cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and hemoglobin were analyzed from
a database of 103 subjects diagnosed with mental and behavioral disorders due to the use of
drugs and other psychoactive substances (ICD-10:  F10-F19)  in  the Institute of  Neurosciences
(INC).  Consumed drugs were alcohol,  cocaine, amphetamines,  MDNA, opioids,  marijuana, and
psychotropic drugs. 
Results: The medians of hemoglobin, total cholesterol, HDL, and creatinine statistically differed
between  genders  and  age  groups.  There  were  more  cases  of  low  blood  hemoglobin  and
hyperglycemia  levels  in  men,  (20.4,  and  8.7%,  respectively)  than  women  (4.9%,  and  0%,
respectively). There were low levels of fasting glucose in 8.8% of our sample. Serum creatinine
levels were significantly increased in subjects aged 30 or more. 
Conclusions: In  our  sample,  there  were  statistically  different  medians  of  hemoglobin,  total
cholesterol, HDL, and creatinine among groups of gender and age in drug addicts. All medians
were within the normal range. 
Keywords: Substance-Related Disorders;  Alcoholism; Marijuana Abuse;  Amphetamine-Related
Disorders;  Opioid-Related  Disorders;  Cocaine-Related  Disorders;  Transaminases;  Erythrocyte
Indices; Creatinine; Drug abuse.
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RESUMEN
Introducción: El  abuso de  drogas es  un  problema de salud  pública  en todo el  mundo.  Sus
implicaciones  en  la  salud  humana son  nocivas  y  comprometen  el  estado  nutricional.  Se  ha
demostrado  que  la  desnutrición  tiene  una  prevalencia  moderada  en  los  drogadictos  y  una
prescripción  nutricional  es  significativamente  beneficiosa  para  estos  pacientes.  La  literatura
disponible  sugiere  datos  bioquímicos  de suero sanguíneo alterados en adictos  a  las  drogas.
Nuestro estudio se centró en los biomarcadores nutricionales del suero sanguíneo en adictos a
las  drogas que  no tenían  una  evaluación o  tratamiento nutricional.  Este  estudio  tuvo como
objetivo analizar los biomarcadores nutricionales del suero sanguíneo en sujetos diagnosticados
con adicción a las drogas desde enero de 2010 hasta junio de 2020.
Material y métodos: La investigación fue de cohorte retrospectiva, analítica, observacional y se
basó  en  una  muestra  de  conveniencia.  Los  datos  sobre  AST,  ALT,  glucosa  en  ayunas,  urea,
creatinina, colesterol total, colesterol HDL, colesterol LDL, triglicéridos y hemoglobina en suero
sanguíneo  se  analizaron  a  partir  de  una  base  de  datos  de  103  sujetos  diagnosticados  con
trastornos  mentales  y  del  comportamiento  debido  al  uso  de  drogas  y  otros  sustancias
psicoactivas  (CIE-10:  F10-F19)  en el  Instituto  de  Neurociencias  (INC).  Las  drogas consumidas
fueron alcohol, cocaína, anfetaminas, MDNA, opioides, marihuana y drogas psicotrópicas.
Resultados: Las  medianas  de  hemoglobina,  colesterol  total,  HDL  y  creatinina  difirieron
estadísticamente entre sexos y grupos de edad. Hubo más casos de niveles bajos de hemoglobina
en sangre e hiperglucemia en hombres (20,4 y 8,7%, respectivamente) que en mujeres (4,9% y
0%, respectivamente). Hubo niveles bajos de glucosa en ayunas en el 8,8% de nuestra muestra.
Los niveles de creatinina sérica aumentaron significativamente en sujetos de 30 años o más.
Conclusiones: En nuestra muestra, hubo medianas estadísticamente diferentes de hemoglobina,
colesterol  total,  HDL  y  creatinina  entre  grupos  de  sexo  y  edad  en  drogadictos.  Todas  las
medianas estaban dentro del rango normal.
Palabras  clave: Trastornos  Relacionados  con  Sustancias;  Alcoholismo;  Abuso  de  Marihuana;
Trastornos  Relacionados con Anfetaminas;  Trastornos  Relacionados con Opioides;  Trastornos
Relacionados con Cocaína; Transaminasas; Índices de Eritrocitos; Creatinina; Abuso de drogas.
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INTRODUCTION
Addiction is commonly identified with nonmedical self-administration of drugs, and it is usually
defined  by  characteristics  of  intoxication  or  by  characteristics  of  withdrawal  symptoms  (1).
Understanding of drug addiction has perhaps made the most progress when conceived in terms
of  its  underlying  neuropsychological  processes  (2).  Classic  ideas  of  Pavlovian  conditioning,
positive reinforcement,  opponent motivational  processes,  and cognitive control  have all  been
shown to play a role not only in explaining bizarre behavioral symptoms of drug addicts, but also
in relating the behavior to underlying dysfunctional neural networks(3). 
Facets  other  than  pharmacological  therapy  include  treatment  for  withdrawal  or  addiction,
nutrition support, and potential for transmission of infectious diseases(4).  Nutrition education
contributes  to  changes  in  eating  environments  to  facilitate  dietary  behavior  changes  in
community residential substance-abuse settings(5).
Drug abuse and blood serum biomarkers
There are some neurobehavioral similarities between appetites for drugs and foods(6). There is a
relationship between imbalances due to diet and substance use(7).  Although the relationship
between  alcohol  intake  and  overweight  development  is  highly  controversial,  some  possible
mechanisms responsible for this effect are an addition to energy from other sources due to heavy
drinking  or  binge  drinking,  little  effect  on  satiety,  possible  influence  over  energy  intake  by
inhibiting the effects of leptin, or glucagon-like peptide-1 (GLP-1) and increasing cholecystokinin,
the primary use of alcohol for heat production, and lifestyle of subjects(8). Research on ghrelin's
role  in  alcoholism/alcohol  use  disorder  (AUD)  in  general  present  evidence  that  the  ghrelin
system seems to activate the mesolimbic dopaminergic system via its GHS-R1A receptor and
ghrelin  receptor  antagonists  attenuate  activity  within  this  system(9).  Ghrelin  receptor
antagonists may be of use in reducing craving and alcohol consumption, or in promoting long-
term abstinence following detoxification(10). However, the administration of such agents would
be  expected  to  lead  to  significant  weight  loss  if  used  chronically(10).  A  study  with  patients
undergoing alcohol and drug treatment found a high level of micronutrient malnutrition (mainly
vitamin A, iron, and potassium) and risk related to a poor appetite and diet quality. Moreover,
81% of all participants were at significant risk of future weight loss owing to a poor appetite, and
the prevalence of moderate malnutrition according to the Subjective Global Assessment (SGA)
was 24%(11).  
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Cannabis  has  been  used  since  ancient  times  to  relieve  neuropathic  pain,  lower  intraocular
pressure, increase appetite, and decrease nausea and vomiting(12–14). Recent studies in humans
show that, in addition to absolute amounts of omega-6 and omega-3, fatty acid intake, a higher
omega-6/omega-3 ratio plays an important role in increasing the development of obesity via
both arachidonic acid eicosanoid metabolites and hyperactivity of the cannabinoid system(15).
However, a meta-analysis revealed significantly reduced body mass index and rates of obesity in
Cannabis  users,  in  conjunction  with  increased  caloric  intake,  by  rapid  and  long-lasting
downregulation of CB1R following acute Cannabis consumption that reduces energy storage and
increases metabolic rates(16).
Excessive salt intake is related to high blood pressure in humans. Opioid signaling powerfully
influences  multiple  components  of  the  circuitry  incentive  salience  for  salt,  and  further
characterizing these roles is important for human health(17). Regarding pregnant women, lower
body mass index and folate, B12, and iron deficiencies were found in women with opioid use
disorder (OUD) compared with women without OUD(18).
Amphetamines suppress appetite by increasing the synaptic availabilities of norepinephrine and
dopamine in the hypothalamus and subsequently activates the norepinephrine - and dopamine-
dependent mechanisms that attenuate the central nervous system control of food intake(19). In
addition to the catecholamine effects, recent studies have reported that the interaction between
hypothalamic dopamine and neuropeptide Y (NPY), an orexigenic neuropeptide, plays a key role
in the anorectic effect of amphetamines(20). A systematic review including overweight and obese
adults with binge-eating disorder found that lisdexamfetamine reduced weight and appetite(21). 
Cocaine,  a  serotonin-norepinephrine-dopamine  reuptake  inhibitor  that  serves  as  an  illegal
stimulant,  appetite  suppressant,  and  anesthetic,  also  causes  vasoconstriction  and
rhabdomyolysis(22). One reason for its effect as an appetite suppressant could be that sigma-1
receptor  ( 1R)  mediates  cocaine  anorectic  effects  by  interacting  in  neurons  withσ
growth/hormone/secretagogue (ghrelin)  receptors.  On the other hand,  cocaine use has been
related to excessive body weight gain when individuals enter treatment and stop using it. Chronic
cocaine exposure may enhance food consumption by modulating 5-HT neurotransmission in the
arcuate nucleus directly via SERT inhibition, and indirectly by reducing leptin production through
its  peripheral  effects.  The  specific  appetite  for  fat  may,  however,  be  modulated by cocaine’s
excitatory  effects  on  the  hypothalamic-pituitary-adrenal  axis  (HPA)  through  the  release  of
hypothalamic corticotropin-releasing factor (CRF)(23). 
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Macronutrients increase the odds of  substance use and micronutrients decrease the odds of
substance use, especially among females. Besides, the nutrient imbalance is a particularly strong
predictor of substance use for both males and females(24). Dilutional hyponatremia is mainly
caused by direct stimulation of antidiuretic hormone (ADH) secretion by ecstasy (MDMA). Females
using ecstasy could be at increased risk of developing severe hyponatremia than males(25).
Malnutrition is a major consequence due to substances replacing nutrients and interfering with
their  metabolism(26)  and  is  related  to  complications  in  wound  healing  and  infections(27).
Subjects with substance use disorder could present a significant deficiency of serum folic acid
and B12 levels(28). Low blood levels of folic acid and B12 could result in anemia characterized by
fatigue, loss of energy, dizziness, tachycardia, and conjunctival pallor.
Overweight and obesity promote chronic low-grade inflammation due to an adipokines synthesis
increase (TNF , IL-6, MCP-1, and resistin), which can cause harm kidneys, liver, pancreas, andα
heart. Abnormal blood serum parameters can suggest disturbances in the homeostasis of such
body organs(29).  
Poor nutritional status in AUD and drug use disorder (DUD) severely impacts their physical and
psychological health, which may impede their ability to resist substances of abuse and recover
their health(30).
As described above, malnutrition-related alterations result in interactions between body organs'
functionality  and  biological  processes  that  would  be  evidenced  in  biochemical  parameters.
Moreover, blood serum biochemical data are used to complement the assessment of nutritional
status.  Small  improvements  in  the  nutritional  environment  may  translate  to  large  gains  in
mental health and wellbeing at a population level(4).
Senescence is characterized by a decline in renal and liver functions; however, this decline could
begin  from adulthood depending on childhood lifestyle.  Some factors  could  promote  such a
decline as unhealthy food intake, chronic diseases, pathogens, and drug abuse. It is known that
cocaine and marijuana could promote renal and liver damage. Therefore, this study aimed to
analyze nutritional serum biomarkers in subjects diagnosed with drug addiction from January
2010 to June 2020.
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MATERIAL AND METHODS
Study design and biochemical parameters
The  research  was  a  retrospective  cohort,  analytical,  observational,  and  was  based  on  a
convenience sample. Information about blood serum aspartate aminotransferase (AST), alanine
aminotransferase (ALT), fasting glucose, urea, creatinine, total cholesterol, HDL cholesterol, LDL
cholesterol, triglycerides, and hemoglobin were analyzed from a database of 103 subjects from
the Institute of Neurosciences of Guayaquil (INC). Reference ranges for blood tests from the INC
(See Table  AM1 in  additional  materials:
http://www.renhyd.org/index.php/renhyd/article/view/1157/743) were considered. Each blood
test was carried out during the first week of admission to the INC in the absence of symptoms
related to acute toxicity or abstinence syndrome, and with negative rapid tests for drugs (cocaine,
amphetamines,  3,4-methylenedioxymethamphetamine  (MDNA),  opioids,  marijuana,  and
psychotropic drugs).  Patients were admitted to the drug addiction rehabilitation program from
the  Addictive  Behavior  Unit  (UCA)  from the  INC from January  2010 to  June  2020.  Inclusion
criteria involved informed consent, age between 18 and 67 years, and clinical history of chronic
abuse  of  alcohol,  marijuana,  amphetamines,  opioids,  and  cocaine  (hydrochloride,  base,  and
crack). Exclusion criteria involved the presence of chronic diseases (liver, kidney, and pancreas)
that  limit  compliance  with  the  research  program  diagnosed  by  medical  examination  and
laboratory tests. Subjects were under medical treatment. No sensitive personal information was
included, analyzed, or distributed. Subjects submitted informed consent, and the INC supported
the research protocol.  In the beginning, we wanted to compare  serum nutritional biomarkers
between adults and the elderly, but we had a very limited number of older adults. Considering
that these groups are highly uneven, we determined that the best way to solve this issue was to
divide our sample into two even groups (age <30 and ≥30).
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Figure 1. Study design.
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Research protocol
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1200 records about blood
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1097 medical records with
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103 medical records met
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Statistical analyses
Descriptive characteristics of nutritional biomarkers in our sample were expressed as medians
with  interquartile  ranges,  and  percentages  for  quantitative  and  categorical  variables,
respectively.   The normality was analyzed with the  Kolmogorov-Smirnov test. Mann–Whitney U
test was applied to determine significant differences among medians of the groups (gender and
ages <30 and ≥30). Fisher's exact test was used to determine significant differences between the
percentages  of  abnormal  blood  serum biomarkers  and  genders.  Analyses  were  adjusted  for
confounding factors including gender and age when these were not the exposure. The group
difference  was  considered  statistically  significant  for  p  <  0.05.  There  were  1097  uncomplete
medical records because 4 years ago there was no admission protocol requesting all laboratory
tests  included  in  this  research.  However,  missing  data  were  not  included  in  the  statistical
analysis. All data were analyzed with RStudio version 1.3.1073. 
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RESULTS
Nutritional serum markers
The hemoglobin median was significantly higher in men than women and was found within the
normal range in both genders (Table 1). However, we found more cases of low blood hemoglobin
levels in men (20.4%) than in women (4.9%) (Table 2). The glucose median was found within the
normal range for both genders and the difference was not statistically significant (Table 1). The
prevalence of abnormal values regarding blood glucose in genders differed significantly (Table 2).
HDL values were significantly higher in women than in men. In contrast, the median creatinine
was significantly higher in men than in women (Table 1). On the other hand, hemoglobin and
HDL  were  within  normal  range  parameters.  In  subjects  aged  30  or  more,  we  observed  a
significant increase in the medians of total cholesterol, and creatinine (Table 1). Reference ranges
can be found in Table AM1 in additional materials.
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Statistical significance *** p  <0.001,  ** p <0.01,  * p  <0.05.  n: Sample Size.  LDL: Low Density
Lipid. HDL: High Density Lipid. IQR: Interquartile range. yo: years old. Mann–Whitney U test was
applied  to  determine  significant  differences  among  medians  of  the  groups.  None  of  the
medians was found outside the reference values. Serum hemoglobin, total cholesterol, HDL
and creatinine were significantly different among groups.
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Men - 20.4 55.3 0.602
Women - 4.9 19.4
Glucose 
Men 8.7 3.9 63.1 0.023*
Women 0.0 4.9 19.4
Total cholesterol 
men 7.8 - 68 0.479
women 3.9 - 20.4
LDL 
men 1.9 - 73.8 0.091
women 2.9 - 21.4
HDL 
men - 31.1 44.7 0.029*
women - 3.9 20.4
Triglycerides 
men 19.4 - 56.3 0.021*
women 1 - 23.3
Creatinine
men 8.7 0.0 67.0 0.343
women 1.9 1 21.4
Urea
men 9.7 0.0 66.0 0.227
women 1.9 1 21.4
AST
men 12.6 - 63.1 0.755
women 2.9 - 21.4
ALT
men 14.6 - 61.2 0.551
women 2.9 - 21.4
Statistical significance*** p  <0.001,  ** p <0.01,  * p  <0.05.  LDL:  Low Density Lipid.  HDL: High
Density Lipid.  AST: Aspartate Aminotransferase.  ALT: Alanine Aminotransferase. Fisher's Exact
Test was applied to determine associations between genders and percentages. According to our
results,  we would expect more  men experiencing abnormal  glucose,  triglycerides,  and HDL
blood levels than women.
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Men  presented  higher  percentages  of  high  serum  levels  of  total  cholesterol,  LDL,  and
triglycerides  (7.8,  1.9,  and  19.4%,  respectively)  than  women  (3.9,  2.9,  and  1%,  respectively).
However, only the percentages regarding categorical variables (high, normal, or low blood levels)
of glucose, HDL, and triglycerides were statistically significant (Table 2). 
Kidney and liver serum markers
Regarding high levels of creatinine, urea, AST, and ALT, the total sample showed 10.6%, 11.6%,
15.5%,  and  17.5%,  respectively.  Men  had  a  higher  prevalence  of  abnormal  levels  of  these
biomarkers compared to women, but such percentages were not statistically different (Table 2). 
Despite  all  these  differences  in  blood  serum values  between  men and  women,  none  of  the
medians were found outside the reference ranges (Table 1). Reference ranges are in Table AM1 in
additional materials.
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DISCUSSION
In this study, abnormal levels in kidney and liver biomarkers, hemoglobin, glucose, and
lipids were  found in our subjects.  However,  their  medians  were found within reference
ranges. In drug addicts, we will probably find more men and people aged more than 30
experiencing dyslipidemia and diseases related to kidneys and liver compared to women
and people aged less than 30. 
According  to  the  INC,  the  most  common  admission  diagnosis  is  opiates  drug
addiction(heroin  type).  In  crack  cocaine  users,  Escobar  et  al.  found  hemoglobin  and
hematocrit  levels  below  normal  for  32.4  and  30.6%  of  patients,  respectively(31).
Considering normal parameters, a large part of the sample (60.2%) had low levels of HDL
cholesterol  and  high  levels  of  triglycerides  (38%)(31).  We  found  similar  values  for  low
hemoglobin levels and high levels of triglycerides (25.3 and 20.4%, respectively). 35% of our
sample presented low HDL levels. Iron and hemoglobin metabolism are tightly related to
the kidneys. Kidneys are responsible for the erythropoietin synthesis, which promotes de
novo red blood cells from the bone marrow(32). Any renal harm may result in anemia,
including harm from drug abuse. Other factors that could promote anemia are subclinical
or  undiagnosed diseases,  food insecurity,  poverty,  and difficult  living  conditions(33).  As
described in the introduction, once individuals enter treatment and stop using cocaine,
their  appetite  (affected  by  chronic  cocaine  use)  could  encourage  excessive  calorie
consumption.  Furthermore,  without  nutritional  counseling,  this  excessive  energy  intake
could explain the moderate prevalence of dyslipidemia in our sample. In one study, cocaine
users  reported  significantly  higher  levels  of  dietary  fat  and  carbohydrates  as  well  as
patterns of uncontrolled eating, and their fat mass was significantly reduced compared
with their  non-drug using peers(34).  Although our study did not show this data,  future
research  should  explore  more  deeply  chronic  cocaine  use,  recovery  periods,  and
endogenous nutrients metabolism.
According to Zhang Y et al.,  Zhang M et al.,  and Lv et al.,  methamphetamine abuse in
humans induces a significant decrease in fasting blood glucose(35–37). We found low levels
of fasting glucose in 8.8% of our sample. Even though we did not include subjects with
diabetes, it can be highlighted that the effect of substance abuse on glycated hemoglobin
and postprandial blood glucose in patients with diabetes was not significant in a review by
Ojo et al(38). However, while the value was slightly lower concerning postprandial blood
glucose,  this  was  slightly  higher  in  relation  to  glycated  hemoglobin  (HbA1c)  in  the
substance abuse group compared with control. On the other hand, the effect of substance
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abuse on fasting blood glucose was significant (p = 0.03) compared with control, but this
was attenuated following a sensitivity test. This would suggest that substance abuse on
fasting blood glucose is not very reliable or transient. A range of factors, including narcotic
withdrawal,  intercurrent infections,  eating habits,  characteristics of drugs, and patients'
erratic  lifestyle,  may  explain  the  outcome(38).  Drug  abuse  increases  the  risk  of
hypoglycemia, compounded by erratic dietary habits(39). Studies in humans and a variety
of preclinical  models indicate that acute administration of  alcohol  can lead to either  a
reduction or no change in the circulating concentration of glucose. However, hypoglycemia
would only be anticipated in humans with AUD who also have a relatively poor nutritional
status or  severely  impaired liver  function(40).  However,  another study considering that
moderate alcohol intake may increase the risk of type 2 diabetes, found that one-week
alcohol abstinence improved hepatic insulin sensitivity and fasting plasma glucose in non-
obese  Japanese  men with  mildly  elevated  fasting  plasma glucose  and  drinking  habits
alcohol(41). Therefore, it could be interesting to explore these biomarkers on subjects with
chronic diseases and drug abuse.
Zhang et al. found that ALT, creatine kinase, and creatinine biochemical serum values in
humans were significantly increased in the methamphetamine group. Serum calcium and
albumin were  found to  be  significantly  decreased in  the  methamphetamine group(35).
However, Lu et al. did not observe any clinically significant association between current or
past self-reported marijuana use and measures of kidney function(42). In our sample, the
high levels  of  serum ALT,  AST,  and  creatinine  corresponded  to  17.5,  15.5,  and 10.6%,
respectively. Anabolic androgenic steroids, synthetic cannabinoids (also known as “Spice”
or “K2”), ecstasy (formally known as MDMA), and cocaine and its levamisole-adulterated
counterpart are common or emerging drugs of abuse with severe nephrotoxic effects about
which  both the  community  and health  care  providers  should  become more  aware(22).
Levamisole  has  been  increasingly  used  as  an  adulterant  of  cocaine  in  recent  years,
emerging as a public health challenge worldwide and its toxicity manifests clinically as
systemic  vasculitis,  consisting  of  cutaneous,  hematological,  and  renal  lesions(43).  An
estimated one-third of individuals with a history of opioid misuse or addiction are thought
to have AUD regarding the liver. Additionally, opioids may also directly contribute to or
exacerbate liver disease because some opioids are metabolized in the liver via the P450
system, and it has been shown and elevation in biochemical markers, particularly alanine
aminotransferase, lactate dehydrogenase, and lipid peroxides among chronic heroin users
thus suggesting direct hepatotoxic effects(44). Studies relating to cannabis use and liver
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health remain unclear. While some studies have suggested possible associations between
cannabis consumption and hepatomegaly, others have suggested a decreased prevalence
of  nonalcoholic  fatty  liver  disease  (NAFLD),  and  significantly  lower  odds  of  developing
steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma in alcohol abusers who
also used marijuana. Possible negative effects on the liver could be due to underlying viral
infections, which are common among marijuana users. Furthermore, four cases of hepatic
failure  associated  with  cannabis  or  its  synthetic  analogs  have  been  reported  in  the
literature(45).
Zhang  M  et  al.  observed  significant  decreases  in  total  cholesterol  and  triglycerides  in
methamphetamine-dependent patients compared to the control group(36). Our study was
observational, not experimental. Thus, we are limited to specify that we did not observe low
serum levels of total cholesterol and triglycerides. 11.7 and 20.4% of our sample showed
high levels of cholesterol and triglycerides, respectively.  Differences in body composition
could  explain  statistically  significant  differences  regarding  medians  and  genders.  It  is
known that men have more muscle and less adipose tissue than women, and this condition
could result in higher levels of hemoglobin and creatinine. However, high levels of serum
creatinine could suggest kidney disease. HDL increase in women compared to men could
be  explained  by  their  complex  lipid  metabolism  due  to  hormones,  breastfeeding,  and
preparation for pregnancy in the future. People aged 30 or more had significantly higher
levels of serum creatinine, possibly suggesting initial stages of kidney disease. As described
in  the  introduction,  organs  functions  decline  with  age.   Their  different  lifestyles  and
conditions  could  explain  statistically  significant  differences  regarding the  prevalence  of
abnormal serum biomarkers between genders.
The drug addiction treatment from INC is designed in 3 components. Such components are
“general  services”  that  includes  meals,  hygiene,  and  nursing  care;  “psychotherapy
program” that includes individual therapy, group therapy, crisis intervention, family and
multifamily therapy, a quality-of-life program for physical exercise training, and social and
recreational  skills  development  through  healthy  use  of  free  time;  and  “occupational
therapy and pharmacotherapy” carried out according to individual needs.
Nutrition services are not part of the 3 components described above. Nonetheless, nutrition
plays a key role in the treatment of drug addicts. Nutrition services should be implemented
to screen for nutritional risks daily. This will help to determine which patients are at high
risk for undernutrition and thus, rapidly implement nutrition care. A good nutritional status
will promote life expectancy and quality.  
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The study limitations involve lack of monitoring of prescribed medicines consumption in
follow-up consultations, lack of nutritional counseling because there are no dietitians in the
INC,  and 4 years  ago there  was no admission protocol  requesting  all  laboratory  tests
included  in  this  research.  Some feasible  confounding  factors  would  be  a  lack  of  deep
analysis of food insecurity, poverty, and difficult living conditions among subjects. These
could be confounding factors because they can decrease food intake, resulting in abnormal
blood serum nutritional biomarkers.
CONCLUSIONS
There  were  statistically  different  medians  of  hemoglobin,  total  cholesterol,  HDL,  and
creatinine among groups of gender and age in drug addicts in our sample. All medians
were within the normal range. Considerably high percentages of low levels of hemoglobin,
HDL,  and  high  levels  of  total  cholesterol,  triglycerides,  LDL,  and  liver  enzymes  were
observed in men. Healthcare professionals should closely monitor red blood cells, blood
lipids, kidneys, and liver status in this population. Further studies exploring the relationship
between drug abuse and nutritional status are needed.
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